Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 5;48(45):8029-8033.
doi: 10.1016/j.tetlet.2007.09.037.

Synthetic methodology for the preparation of N-hydroxysulfamides

Affiliations

Synthetic methodology for the preparation of N-hydroxysulfamides

Krishnaswamy Devanathan et al. Tetrahedron Lett. .

Abstract

A convenient synthesis of a variety of substituted N-hydroxysulfamides from chlorosulfonyl isocyanate is reported. Alkyl groups can be introduced selectively on the N-Boc nitrogen of key intermediates 1a or 1b using the Mitsunobu reaction with alcohols. Subsequently the nitrogen carrying the silyloxy group can be alkylated under traditional conditions. Deprotection to the desired N-hydroxysulfamide can be achieved in high yields. Using this method, a number of structurally diverse N-hydroxysulfamides have been prepared. The usefulness of this methodology has further been demonstrated by the synthesis of more complex targets such as bis-hydroxysulfamide, 5, and cyclic hydroxysulfamides 7 and 8.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Scheme 2
Scheme 2
Scheme 3
Scheme 3

References

    1. Lori F, Kelly LM, Foli A, Lisziewicz J. Expert Opinion of Drug Safety. 2004;3(4):279. - PubMed
    2. Huang J, Zou Z, Kim-Shapiro DB, Ballas SK, King SB. J. Med. Chem. 2003;46:3748. - PubMed
    3. King SB. Curr. Med. Chem. 2003;10:437. - PubMed
    4. Granik VG, Grigor'ev NB. Russ. Chem. Bull. Int. Ed. 2002;51:1375.
    5. Paz-Ares L, Donehower RC. In: Cancer Chemotherapy and Biotherapy-Principles and Practice, ch. 11. 3rd edn. Chabner BA, Longo DL, editors. Philadelphia: Lippincott, Williams, and Wilkins; 2001. pp. 315–328.
    6. Frank I. J. Biol. Regulators and Homeostatic Agents. 1999;13(3):186. - PubMed
    7. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP. Medicine. 1996;75:300. - PubMed
    1. Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A, Supuran CT. Bioorg. Med. Chem. 2007;15:2298. - PubMed
    2. Wilkins PC, Jacobs HK, Johnson MD, Gopalan AS. Inorg. Chem. 2004;43(24):7877–7881. - PubMed
    3. Lee MJC, Shoeman DW, Goon DJW, Nagasawa HT. Nitric Oxide: Biology and Chemistry. 2001;5:278. - PubMed
    4. Scozzafava A, Supuran CT. J. Med. Chem. 2000;43:3677. - PubMed
    5. Mincione F, Menabuoni L, Briganti F, Mincione G, Scozzafava A, Supuran CT. J. Enzyme Inhib. 1998;13:267. - PubMed
    1. Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Med. Res. Rev. 2006;26:767. - PubMed
    2. Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Expert Opinion on Therapeutic Patents. 2006;16(1):27. - PubMed
    3. Casini A, Winum J-Y, Montero J-L, Scozzafava A, Supuran CT. Bioorg. Med. Chem. Lett. 2003;13:837. - PubMed
    4. Park JD, Kim DH, Kim S-J, Woo J-R, Ryu SE. J. Med. Chem. 2002;45:5295. - PubMed
    5. Tozer MJ, Buck IM, Cooke T, Kalindjian SB, McDonald JM, Pether MJ, Steel KIM. Bioorg. Med. Chem. Lett. 1999;9:3103. - PubMed
    1. Winum J-Y, Innocenti A, Nasr J, Montero J-L, Scozzafava A, Vullo D, Supuran CT. Bioorg. Med. Chem. Lett. 2005;15:2353. - PubMed
    1. For some recent reviews on design of carbonic anhydrase inhibitors see: Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Curr. Topics Med. Chem. 2007;7:835.Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A. Curr. Med. Chem. Cardiovascular and Hematological Agents. 2004;2:49.Supuran CT, Scozzafava A, Casini A. Med. Res. Rev. 2003;23:146.

LinkOut - more resources